PPA
RMD icon

Pacific Point Advisors’s ResMed RMD Stock Holding History

Pacific Point Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$343K Buy
1,526
+11
+0.7% +$2.74K 0.18% 106
2025
Q4 		$365K Sell
1,515
-4,726
-76% -$1.21M 0.2% 105
2025
Q3 		$1.71M Buy
6,241
+21
+0.3% +$5.74K 1% 22
2025
Q2 		$1.6M Buy
6,220
+341
+6% +$81.3K 0.87% 27
2025
Q1 		$1.32M Buy
5,879
+573
+11% +$134K 0.73% 40
2024
Q4 		$1.28M Buy
+5,306
New +$1.28M 0.78% 37

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pacific Point Advisors's RMD Position: Q1 2026 in Review

Pacific Point Advisors increased its ResMed (RMD) stake by 0.73% in Q1 2026, buying an estimated $2.74K and bringing the position to 1,526 shares worth $343K. The position accounts for 0.18% of the portfolio, ranked #106.

Pacific Point Advisors first reported a position in RMD in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.71M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Pacific Point Advisors held 1,526 shares of ResMed worth $343K as of Q1 2026.
  • Pacific Point Advisors bought 11 ResMed shares in Q1 2026, an estimated $2.74K.
  • ResMed made up 0.18% of Pacific Point Advisors's portfolio in Q1 2026, its #106 holding.
  • Pacific Point Advisors first reported a position in ResMed in Q4 2024 and has held it in 6 quarters since.
  • Pacific Point Advisors's ResMed position peaked at $1.71M in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Pacific Point Advisors's 13F filing for Q1 2026, filed 4 May 2026.